[JANX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -73.48%
YoY- -757.17%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 2,365 1,589 1,616 1,159 482 380 0 -
PBT -16,888 -13,410 -13,416 -10,766 -6,206 -2,284 -1,655 372.46%
Tax -373 -264 -74 137 46 0 0 -
NP -16,515 -13,146 -13,416 -10,766 -6,206 -2,284 -1,655 365.46%
Tax Rate - - - - - - - -
Total Cost 18,880 14,735 15,032 11,925 6,688 2,664 1,655 409.02%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -698.31 -827.31 -830.20 -928.90 -1,287.55 -601.05 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.40 -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 111.98%
EPS Diluted -0.40 -0.32 -0.33 -0.26 -0.62 -0.06 -0.13 111.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.